• ACE2 Peptidase Specificity and Angiotensin (1-7)

  2026-09-17

  Saulnier and colleagues used a fluorogenic ACE2 activity assay to define how angiotensin peptide length and terminal residues influence competition with an ACE2 substrate. Their findings identify Ang II and Ang III as the most effective natural ACE2 substrates in this assay and clarify why Angiotensin (1-7) is primarily a product rather than a competing substrate.

• Bestatin Hydrochloride: Mechanism and Research Use

  2026-09-17

  Bestatin hydrochloride, also called Ubenimex, is a research inhibitor of aminopeptidase N/CD13 and aminopeptidase B. Evidence spans rat neuronal peptide processing and product-reported tumor angiogenesis models, but these domains require separate interpretation and experimental controls.

• Gastrodin, AT1 Signaling, and Reactive Astrocytes

  2026-09-16

  A 2024 European Journal of Neuroscience study shows that inflammatory microglia-conditioned medium reshapes astrocytic renin–angiotensin system, SIRT3, phenotype, cytokine, and neurotrophic markers. By combining gastrodin treatment with AT1 inhibition, the study provides a cell-based framework for examining how microglia-to-astrocyte signaling contributes to neuroinflammation.

• Captopril: ACE Inhibition and Assay Design

  2026-09-16

  Captopril is a potent ACE inhibitor for hypertension research and mechanistic studies. This guide connects ACE inhibition with bradykinin-sensitive functional assays while separating validated evidence from exploratory anticancer applications.

• Proteoform-Specific Drug Interactions in Native Membranes

  2026-09-15

  Lutomski and colleagues developed a native mass-spectrometry workflow that releases membrane proteins and signaling complexes directly from retina rod disc membranes while retaining proteoform and interaction information. Their results show that lipid modifications can regulate G-protein assembly and that Vardenafil and sildenafil exhibit differential off-target reactivity toward retinal PDE6, demonstrating why drug interactions should be examined in native membrane environments.

• Metoprolol BA2737 for Reliable Cell Assays

  2026-09-15

  Learn how Metoprolol (SKU BA2737) can be incorporated into cell viability, proliferation, cytotoxicity, inflammation, and angiogenesis workflows without confusing pharmacological effects with assay artifacts. This scenario-based guide emphasizes controlled dosing, fresh solution handling, disease-state interpretation, and practical product-selection criteria.

• Calpeptin Workflows for Pulmonary Fibrosis Research

  2026-09-14

  Calpeptin provides a practical way to probe how calcium-dependent protease activity intersects with cell death, fibroblast activation, and inflammatory signaling. This workflow-focused guide connects calpain inhibition with pulmonary fibrosis research while emphasizing controls, readout selection, and troubleshooting.

• Angiotensin 1/2 (1-6) Research Workflow

  2026-09-14

  Build reproducible cardiovascular, renal, and receptor-binding assays around the sequence-defined Asp-Arg-Val-Tyr-Ile-His hexapeptide. This workflow combines practical handling guidance with a cautious translation of recent spike–receptor binding findings into testable assay designs.

• Captopril: ACE Inhibition Research Guide

  2026-09-13

  Captopril is an ACE inhibitor used to study angiotensin signaling, blood-pressure control, and bradykinin-linked biology. Its strongest translational evidence is cardiovascular, while anticancer activity and apoptosis induction in cancer cells remain preclinical research findings.

• Fumagillin Workflows for MetAP-2 and Angiogenesis

  2026-09-12

  Fumagillin connects mechanistic MetAP-2 inhibition with practical angiogenesis and protozoan assay workflows. This guide explains how to prepare the compound, build concentration-response experiments, interpret the Azumiobodo hoyamushi evidence, and troubleshoot solubility or vehicle-related variability.

• Angiotensin 1/2 (1-6): Assay Design Guide

  2026-09-11

  Angiotensin 1/2 (1-6) is a defined Asp-Arg-Val-Tyr-Ile-His hexapeptide for dissecting renin-angiotensin signaling and vascular assays. This guide focuses on experimental design, preanalytical control, and how to interpret emerging spike-receptor binding data without overstating biological conclusions.

• Z-VAD-FMK: A Causal Map of Cell Death

  2026-09-11

  Z-VAD-FMK is more than an apoptosis blocker: it is a perturbation tool for distinguishing caspase-dependent apoptosis from RIPK1-linked necroptosis. This guide combines mechanistic chemistry, assay design, and insights from a CRISPR-based RIPK1 study to improve interpretation in apoptotic pathway research.

• GSH and GSSG Assay Kit for Tumor Redox Studies

  2026-09-10

  Use paired GSH and GSSG measurements to connect hypoxic tumor biology with immune-cell metabolic adaptation. This workflow emphasizes sample preservation, selective GSSG analysis, matrix control, and practical interpretation rather than treating one redox value as a complete mechanistic answer.

• Metal-Free Carbon Nanozymes for ALP Detection

  2026-09-10

  Hsieh and colleagues developed a metal-free carbon-dot nanozyme assay that converts alkaline phosphatase hydrolysis of pyrophosphate into a colorimetric turn-on signal. Kinetic analysis showed that pyrophosphate inhibits the carbon dots at a site distinct from the catalytic site, supporting sensitive ALP measurement while reducing metal-ion-related interference.

• Demethyleneberberine Workflows for Inflammation & NSCLC

  2026-09-09

  Demethyleneberberine (DMB) supports mechanism-driven inflammation, mitochondrial, and cancer workflows rather than single-endpoint screening. This guide connects practical cell and animal model design with solvent handling, pathway-resolved assays, and troubleshooting for UC, autoimmune hepatitis, and NSCLC research.

7755 records 1/517 page Next 12345 下5页 Last page